Related Experiment Video
Updated: Apr 29, 2026

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment
Published on: June 21, 2022
Intratumor heterogeneity and its impact on drug distribution and sensitivity
I Fuso Nerini1, L Morosi1, M Zucchetti1
1IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri," Laboratory of Cancer Pharmacology, Department of Oncology, Milan, Italy.
Abstract:
We provide an overview of the available information on the distribution of chemotherapeutics in human tumors, highlighting the progress made to assess the heterogeneity of drug concentrations in relation to the complex neoplastic tissue using novel analytical methods, e.g., mass spectrometry imaging. The increase in interstitial fluid pressure due to abnormal vascularization and stiffness of tumor stroma explains the variable and heterogeneous drug concentrations. Therapeutic strategies to enhance tumor drug distribution, thus possibly increasing efficacy, are discussed.
Insights
Chemotherapy distribution in human tumors is heterogeneous due to increased interstitial fluid pressure. Novel methods like mass spectrometry imaging help assess this, guiding strategies to improve drug delivery and cancer treatment efficacy.
Area of Science:
- Oncology
- Pharmacology
- Biomedical Engineering
Background:
- Chemotherapy efficacy is limited by heterogeneous drug distribution within tumors.
- Tumor microenvironment factors, including abnormal vasculature and stromal stiffness, contribute to this heterogeneity.
- Understanding drug distribution is crucial for optimizing cancer therapy.
Purpose of the Study:
- To review current knowledge on chemotherapeutic distribution in human tumors.
- To highlight advancements in analytical techniques for assessing drug concentration heterogeneity.
- To discuss therapeutic strategies for improving tumor drug delivery.
Main Methods:
- Review of existing literature on drug distribution in neoplastic tissues.
- Application of novel analytical techniques, such as mass spectrometry imaging, for precise drug quantification.
- Analysis of factors influencing interstitial fluid pressure and drug penetration.
Main Results:
- Chemotherapeutic concentrations vary significantly within human tumors.
- Increased interstitial fluid pressure, caused by abnormal tumor vascularization and stiff stroma, is a key factor in heterogeneous drug distribution.
- Mass spectrometry imaging enables detailed assessment of drug concentration landscapes.
Conclusions:
- Heterogeneous drug distribution is a significant challenge in cancer chemotherapy.
- Therapeutic strategies aimed at modulating the tumor microenvironment and enhancing drug delivery are essential for improving treatment outcomes.
- Advanced imaging techniques are vital for characterizing and addressing drug distribution issues.
More Related Videos
07:54Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
Related Concept Videos
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drug Distribution: Tissue Binding
For...
Factors Affecting Drug Distribution: Tissue Permeability
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...
Drug Distribution: Overview
Initially, the free drug in the...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
Drug toxicity: Idiosyncratic Reactions